Syed A. Hussain
0000-0003-1552-511X
Publication & Citation Trends
Publications
0 total
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial. OA
Cited by 91
Semantic Scholar
TUXEDO: a phase I/II trial of cetuximab with chemoradiotherapy in muscle‐invasive bladder cancer OA
Cited by 4
Semantic Scholar
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial. OA
Cited by 21
Semantic Scholar
A systematic review and network meta-analysis evaluating neoadjuvant treatments in muscle-invasive bladder cancer.
Cited by 0
Semantic Scholar
1734MO Hypoxic bladder cancers have a poorer outcome following hypofractionated vs conventionally fractionated radiotherapy in the BC2001 and BCON randomised trials OA
Cited by 1
Semantic Scholar
Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes OA
Cited by 147
Semantic Scholar
Urological cancer patients receiving treatment during COVID-19: a single-centre perspective OA
Cited by 3
Semantic Scholar
Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study OA
Cited by 4
Semantic Scholar
Research Topics
Bladder and Urothelial Cancer Treatments
(177)
Urinary and Genital Oncology Studies
(93)
Cancer Immunotherapy and Biomarkers
(55)
Renal cell carcinoma treatment
(30)
Prostate Cancer Treatment and Research
(30)
Affiliations
Cedars-Sinai Medical Center
Lahey Hospital and Medical Center
Lancashire Teaching Hospitals NHS Foundation Trust
Trinity Health
Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir